ebalzotan ebalzotan ebalzotan (nae-086) is a selective 5-ht1a receptor agonist. it was under development as an antidepressant and anxiolytic agent but produced undesirable side effects in phase i clinical trials and was subsequently discontinued. ebalzotanclinical dataroutes ofadministrationoralatc codenonelegal statuslegal status in general: uncontrolled identifiers iupac name (3r)-n-(propan-2-yl)-3--3,4-dihydro-2h-chromene-5-carboxamide cas number149494-37-1pubchem cid9797080chemspider7972846uniiwv4b56n49hchemblchembl1742470chemical and physical dataformulac19h30n2o2molar mass318.461 g·mol−13d model (jsmol)interactive image smiles o=c(nc(c)c)c2cccc1oc(n(c(c)c)ccc)cc12